PT - JOURNAL ARTICLE AU - Philip A. Spechler AU - Jennifer L. Stewart AU - Rayus Kuplicki AU - the Tulsa 1000 Investigators AU - Martin P. Paulus TI - COVID-19 vaccine willingness and cannabis use histories AID - 10.1101/2021.04.26.21256109 DP - 2021 Jan 01 TA - medRxiv PG - 2021.04.26.21256109 4099 - http://medrxiv.org/content/early/2021/04/28/2021.04.26.21256109.short 4100 - http://medrxiv.org/content/early/2021/04/28/2021.04.26.21256109.full AB - Background Cannabis use is associated with problematic health-behaviors such as excessive alcohol and tobacco use, and sedentary behavior. Here, we examined the association between cannabis use history and an especially topical health-behavior, willingness to receive a COVID-19 vaccine.Methods COVID-19 vaccine willingness was surveyed in a subset of participants from the Tulsa 1000 Study, which is a longitudinal study of psychiatric treatment-seeking and healthy control participants. We identified 45 participants who completed a COVID-19 vaccine questionnaire and reported more than 10 lifetime cannabis uses. Those participants were compared to a group of 45 individuals with very light (<10) cannabis use histories who were propensity score-matched on age, sex, income, and race. Two-group t-tests and Bayes factor analysis on vaccine willingness were conducted between groups. Exploratory correlation analyses were conducted on vaccine willingness and lifetime cannabis use levels within the cannabis group only.Results Vaccine willingness did not differ between the two groups (t88=0.33, p=.74; BF01=4.3). However, a negative correlation was identified within the cannabis group, such that higher lifetime cannabis use histories correlated with less willingness to receive a vaccine (rho43= -.33, p=.03).Conclusions Although vaccine willingness did not differ between the two matched groups, preliminary evidence suggests that heavy lifetime cannabis use might indicate a reluctance to engage in health-promoting behaviors like receiving a COVID-19 vaccine.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work has been supported in part by The William K. Warren Foundation, and the National Institute of General Medical Sciences Center Grant Award Number 1P20GM121312. The content is solely the responsibility of the authors and does not necessarily represent the views of the WKW Foundation or the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All study protocols were approved by the WCG Institutional Review Board.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data and analysis codes that support the findings of this study are available from the corresponding author upon reasonable request.